BCLC Stage (hepatocellular carcinoma)
BCLC Stage (hepatocellular carcinoma) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the BCLC Stage (hepatocellular carcinoma) → Runs in your browser. No signup, no tracking.
What this is
BCLC Stage (hepatocellular carcinoma) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. BCLC Stage (hepatocellular carcinoma) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329-338. 2022 update: Reig M, Forner A, Rimola J, et al. J Hepatol. 2022;76(3):681-693. Read the source ↗
Worked example: BCLC stage B (intermediate) — transarterial chemoembolization strategy.
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.